News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are

CRADA collaboration opportunities are being offered by the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) to facilitate the development of small molecule compounds early in the development cycle. Both collaborations will focus on

The 2012 Deals of Distinction™ Award was presented to National Institutes of Health (NIH) along with the University of Illinois at Chicago (UIC), who jointly own one patent family, and to Gilead Sciences (Gilead) for license agreements granted to the Medicines Patent Pool, a newly established

In a recently released report, the NIH details its plans for Accelerating Technology Transfer and Commercialization in Support of High Growth Business. The Plan is a response to the October 28, 2011 Presidential Memorandum ( http://1.usa.gov/uHoAA4) that required federal agencies to streamline